IBRX
#1034
ImmunityBio, Inc. - Common Stock
7.6 8 USD
-0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.54%
Variación mensual
+7.87%
Variación en los últimos 6 meses
+62.71%
Cambio anual
+177.26%
Cierres anteriores
7.8 8
Open
7.6 6
Mínimo
7.6 3
High
7.7 1
Volumen
1 010
Financials
- Market Capitalization 8.04 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.02
Relación precio/flujo de caja
51.72
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1023 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.85 USD | +1.75% | -1.33% | +11.39% | +45.86% | 8.55 B USD | ||
| 1033 |  PCVX Vaxcyte, Inc. - Common Stock | 56.38 USD | +0.30% | -2.66% | +13.74% | +33.29% | 8.14 B USD | ||
| 1042 |  IMVT Immunovant, Inc. - Common Stock | 39.44 USD | +1.73% | -1.42% | +18.76% | +105.31% | 8.10 B USD | ||
| 1061 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 61.94 USD | -0.06% | -3.92% | +18.66% | +56.24% | 7.74 B USD |